RACHEL A GERSHENSON

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care HOUSTON, TX NPI 1629604152

General Payments — all program years on this page

$1,148.75

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 42
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $542.79 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $542.7921

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $24.621
2022 $184.355
2023 $396.9915
2024 $542.7921

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078726426 Janssen Biotech, Inc. $27.54 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089425301 Daiichi Sankyo Inc. $27.97 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089425303 Daiichi Sankyo Inc. $27.27 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089425305 Daiichi Sankyo Inc. $27.03 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101104332 Celgene Corporation $13.18 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101104340 Celgene Corporation $23.32 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107164871 ABBVIE INC. $25.27 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116339730 GlaxoSmithKline, LLC. $30.06 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120853607 BeiGene USA, Inc. $21.67 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135855380 Lilly USA, LLC $21.36 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135855384 Lilly USA, LLC $26.60 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135899380 Lilly USA, LLC $27.20 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135922768 Lilly USA, LLC $26.35 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135928386 Lilly USA, LLC $28.88 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137304379 PharmaEssentia USA Corporation $29.34 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137304435 PharmaEssentia USA Corporation $28.25 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137945372 TAIHO ONCOLOGY, INC. $33.66 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141196181 Incyte Corporation $17.93 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141236325 Incyte Corporation $28.74 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144975721 Takeda Pharmaceuticals U.S.A., Inc. $26.52 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147268210 SERVIER PHARMACEUTICALS LLC $24.65 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.